☆ 4.8 Letter

Reducing mortality from 2019-nCoV: host-directed therapies should be an option

LANCET (2020)

Get Full Text
Add to Collection

Journal

LANCET
Volume 395, Issue 10224, Pages E35-E36

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(20)30305-6

Keywords

-

Categories

Medicine, General & Internal

Funding

  1. European & Developing Countries Clinical Trials Partnership
  2. EU's Framework Programme for Research and Innovation
  3. National Institutes of Health Research
  4. Bill & Melinda Gates Foundation - Champalimaud Foundation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.